Century Therapeutics received a rating upgrade following an upward trend in its earnings estimates on July 22, 2025.
2 reports, 1 independent
Updated Jul 22
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Century Therapeutics received a rating upgrade following an upward trend in its earnings estimates on July 22, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Price momentum for Century Therapeutics reflects growing investor interest, involving Momentum.Sub-event
Rating upgrade for Century Therapeutics based on positive earnings outlook.1 source
- Century Therapeutics earned Zacks Rank #2 based on momentum and earnings revisions.
Keep exploring
The entities involved
-
Century Therapeutics (United States)
company in Philadelphia, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksAll You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy Investors might want to bet on Century Therapeutics, Inc. (IPSC), as it has been recently upgraded to a Zacks Rank
- Unknown outlet